M4MM
NY Cannabis Board Hits Equity Target With 57% of Licenses to Social Equity Holders
NEW YORK – New York regulators reported that social and economic equity applicants now control 57% of the state's adult-use Cannabis licenses, a figure that clears the program's initial benchmark and signals steady advancement in ...
Australia’s Medicinal Cannabis Imports Hit Record Highs
SYDNEY – Figures released this week by Australia's Office of Drug Control paint a picture of robust expansion in the country's regulated Cannabis sector, with imports leading the charge alongside steady advances in domestic output ...
California Reinstates 15% Cannabis Excise Tax Through 2028
LOS ANGELES – A measure signed by Governor Gavin Newsom last month took effect on Wednesday, dialing back California's Cannabis excise tax to 15% and holding it steady at that level until at least the ...
DCC and Metrc Advance California Cannabis Safety with QR Recalls
LAKELAND – In a move aimed at strengthening public health protections in the state's regulated Cannabis sector, Metrc has introduced a new recall notification system tied to its Metrc Retail ID™ QR codes. The feature, ...
German Health Ministry Draft Sparks Patient Backlash Over Medical Cannabis Access
FRANKFURT – A recent survey by MedCanOneStop, a German medical Cannabis platform, has highlighted sharp concerns among patients about a proposed amendment from the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG) that would limit ...
Trump’s Potential Cannabis Rescheduling Sparked Stock Rise and Industry Uncertainty
LOS ANGELES – On August 11, 2025, President Donald Trump’s public comments on potentially rescheduling Cannabis from Schedule I to Schedule III under the Controlled Substances Act skyrocketed Cannabis stocks. The AdvisorShares Pure U.S. Cannabis ...
Hemp-Derived THC Beverages Gain Traction as U.S. Alcohol Consumption Declines
LOS ANGELES – Hemp-derived THC beverages generated $382 million in sales in 2024, a marked increase from previous years, yet 2025 projections indicate tempered growth at $571 million, climbing to $756 million by 2029 with ...
NY Cannabis Board Hits Equity Target With 57% of Licenses to Social Equity Holders
NEW YORK – New York regulators reported that social and economic equity applicants now control 57% of the state's adult-use Cannabis licenses, a figure that clears the program's initial benchmark and signals steady advancement in ...
Australia’s Medicinal Cannabis Imports Hit Record Highs
SYDNEY – Figures released this week by Australia's Office of Drug Control paint a picture of robust expansion in the country's regulated Cannabis sector, with imports leading the charge alongside steady advances in domestic output ...
California Reinstates 15% Cannabis Excise Tax Through 2028
LOS ANGELES – A measure signed by Governor Gavin Newsom last month took effect on Wednesday, dialing back California's Cannabis excise tax to 15% and holding it steady at that level until at least the ...
Germany’s Cannabis Law: Maximizing Yield with the Three-Plant Limit
BERLIN — Germany’s new cannabis law, effective April 1, 2024, permits adults to grow up to three plants and possess up to 25 grams of cannabis for personal use. This regulation requires home cultivators to ...
California Pulls Cannabis Products from Shelves Due to Pesticide Concerns
LOS ANGELES- California this week ordered product recalls for five licensed cannabis products, including four vape pens and a vape cartridge, due to contamination with chlorfenapyr, a banned pesticide. These products, sold by West Coast ...
Evolving Hemp Regulations and Market Dynamics in Louisiana
LOS ANGELES- The hemp market is undergoing significant changes as new regulations affect how products are manufactured, sold, and consumed. The legal landscape shapes the future of hemp-derived products, necessitating staying updated on industry trends ...
Pesticide Scandal & Product Recalls Rocks California’s Cannabis Industry
LOS ANGELES--California's cannabis industry is reeling from a recent pesticide scandal that has undermined consumer confidence and highlighted regulatory shortcomings. An investigation by the Los Angeles Times, in collaboration with WeedWeek, revealed alarming levels of ...
The Demise of Chevron Deference: A New Era for Government Regulation and Its Impact on the Cannabis Industry
WASHINGTON, D.C. - In a landmark ruling, the Supreme Court has overturned a 40-year-old precedent known as "Chevron deference," which mandated that courts defer to the interpretations of federal agencies when a law is ambiguous, ...
Majority of North Dakota Voters Oppose Recreational Cannabis Legalization
LOS ANGELES- A recent poll commissioned by the Brighter Future Alliance and conducted by Public Opinion Strategies revealed that 57% of likely North Dakota voters are against the legalization of recreational cannabis for adults over ...
IRS Reaffirms Cannabis as Schedule I Substance; Section 280E Still Applies
WASHINGTON — The Internal Revenue Service (IRS) has issued a reminder that cannabis remains classified as a Schedule I controlled substance and is subject to the limitations of Internal Revenue Code Section 280E until any ...
Growing Interest in Microdosing Among Americans
LOS ANGELES- Americans are increasingly curious about microdosing, a practice involving minimal consumption of psychedelics or cannabis over extended periods, according to a study by the University of California San Diego published in JAMA Health ...
IRS Reaffirms Enforcement of Section 280E Amid Cannabis Industry Pushback
MIAMI, Florida--In a recent announcement, the Internal Revenue Service (IRS) underscored the ongoing enforcement of Internal Revenue Code Section 280E, a tax code provision that has long been a contentious issue for cannabis businesses. The ...
Cronos Group Secures $51 Million Credit Line
LOS ANGELES- Cronos Group's $51 million credit line will enhance production and facilitate global market expansion, positioning the company as a key player in the burgeoning cannabis industry. Canada’s Cronos Group has announced that it ...
Incannex Healthcare Receives FDA Approval for Phase 2 Clinical Trial of Psilocybin Therapy
LOS ANGELES- Incannex Healthcare Inc. a clinical-stage pharmaceutical company, has received approval from the US Food and Drug Administration (FDA) to commence a Phase 2 clinical trial for its psilocybin pharmaceutical formulation, PSX-001, in combination ...
Week’s In Review: Tilray Expands U.S. Presence with Acquisition of Four Molson Coors Craft Breweries; California Seizes Over $120 Million in Illegal Cannabis Since January; North Dakota Voters to Decide on Cannabis Legalization for Third Time
LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's ...
Week In Review: DEA’s Proposed Rescheduling of Cannabis Sparks Public Response; The Battle Over Recreational Cannabis Legalization Heats Up; Harris-Walz Ticket First to Support Federal Cannabis Legalization
LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's ...
Week In Review: Ohio Comes On Line; Texas Cities Advance Cannabis Decriminalization Efforts; Tilray Expands in Portugal; Philippine Lawmakers Push for Medical Cannabis Legalization
LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's ...
Week In Review: Dallas Officials Approve Cannabis Decriminalization Petition for November Ballot; Field Trip Health Ltd. Shares Rise 5.8% Amid Increased Trading Volume; SNDL Announces Major Restructuring to Save $20 Million Annually; Verano buys Cannabists Businesses
LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's ...
